{"id":1819,"date":"2020-08-25T23:44:30","date_gmt":"2020-08-25T23:44:30","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1819"},"modified":"2023-08-29T17:46:42","modified_gmt":"2023-08-29T17:46:42","slug":"incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1819","title":{"rendered":"Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c"},"content":{"rendered":"<p>\u4e34\u5e8a\u671f\u5927\u9ebb\u7d20\u5f00\u53d1\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=IHL&amp;lang=cn\">Incannex Healthcare (ASX: IHL)<\/a>\u5ba3\u5e03\uff0c\u5148\u5bfc\u836f\u7269IHL- 675a\u5728\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(SAARDS)\u65b9\u9762\u7684\u6297\u708e\u6d3b\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\uff0cSAARDS\u662f\u65b0\u51a0\u75c5\u6bd2\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002<\/p>\n<p>\u5728\u4e00\u9879\u6d89\u53ca\u836f\u7269\u6210\u5206\u5927\u9ebb\u4e8c\u915a(CBD)\u548c\u7f9f\u6c2f\u55b9(HCQ)\u7684\u4f53\u5916\u5b9e\u9a8c\u4e2d\uff0cIncannex\u5df2\u7ecf\u786e\u5b9a\u4e86\u80fd\u591f\u5b8c\u5168\u6291\u5236\u4eba\u7c7b\u7ec6\u80de\u4e2d\u708e\u75c7\u751f\u7269\u6807\u5fd7\u7269\u2014\u2014\u7ec6\u80de\u56e0\u5b50\u7684\u6709\u6548\u6d53\u5ea6\u8303\u56f4\u3002<\/p>\n<p>\u4ed6\u4eec\u76ee\u524d\u6b63\u5728\u7b49\u5f85\u4e24\u79cd\u836f\u7269\u8054\u5408\u4ea7\u54c1\u7684\u8bc4\u4f30\u7ed3\u679c\uff0c\u6839\u636e\u8be5\u7ed3\u679c\uff0c\u4e24\u79cd\u836f\u7269\u8054\u5408\u4f7f\u7528\u7684\u4f4e\u5242\u91cf\u7406\u8bba\u4e0a\u53ef\u4ee5\u8fbe\u5230\u76f8\u540c\u7684\u529f\u6548\u6c34\u5e73\uff0c\u6700\u5927\u9650\u5ea6\u5730\u51cf\u5c11\u4e0d\u826f\u53cd\u5e94\u7684\u53ef\u80fd\u6027\uff0c\u4ee5\u53ca\u5b9a\u4e49\u4e3aIHL-675A\u4ea7\u54c1\u7684\u63cf\u8ff0\u3002<\/p>\n<h2>\u6d4b\u5b9a\u65b9\u6cd5<\/h2>\n<p>\u8be5\u5b9e\u9a8c\u89c2\u5bdf\u4e86\u4ece\u4e09\u4e2a\u4e0d\u540c\u7684\u4f9b\u4f53\u4e2d\u5206\u79bb\u51fa\u7684\u4eba\u5916\u5468\u8840\u5355\u6838\u7ec6\u80de(PBMCs)\uff0c\u5e76\u5728\u7ec6\u83cc\u8102\u591a\u7cd6(LPS)\u8bf1\u5bfc\u708e\u75c7\u53cd\u5e94\u4e4b\u524d\u7528\u4e0d\u540c\u6d53\u5ea6\u7684CBD\u6216HCQ\u8fdb\u884c\u5904\u7406\u3002\u5b9e\u9a8c\u4e2d\u4e5f\u52a0\u5165\u4e86\u53ea\u6dfb\u52a0LPS\u7684\u672a\u5904\u7406\u5bf9\u7167\u7ec4\u3002<\/p>\n<p>\u5728\u6bcf\u79cd\u7814\u7a76\u836f\u7269\u548cLPS\u5b58\u5728\u768424\u5c0f\u65f6\u6f5c\u4f0f\u671f\u540e\uff0c\u4f7f\u7528\u57fa\u4e8e\u53d1\u5149\u7684\u68c0\u6d4b\u65b9\u6cd5\u5bf9\u57f9\u517b\u57fa\u4e2d\u5173\u952e\u7684\u708e\u75c7\u7ec6\u80de\u56e0\u5b50\u6c34\u5e73\u8fdb\u884c\u5206\u6790\u3002<\/p>\n<p>Incannex\u7814\u7a76\u53d1\u73b0\uff0cCBD\u548cHCQ\u5448\u201c\u7ebf\u6027\u6297\u708e\u5242\u91cf\u53cd\u5e94\u66f2\u7ebf\u201d\uff0c\u5373\u968f\u7740\u836f\u7269\u6d53\u5ea6\u7684\u589e\u52a0\uff0cPBMCs\u5728LPS\u523a\u6fc0\u4e0b\u4ea7\u751f\u7684\u7ec6\u80de\u56e0\u5b50\u51cf\u5c11\u3002<\/p>\n<p>\u7ec6\u80de\u56e0\u5b50\u662f\u7ec6\u80de\u4fe1\u53f7\u5206\u5b50\uff0c\u5b83\u5728\u514d\u75ab\u53cd\u5e94\u4e2d\u5e2e\u52a9\u7ec6\u80de\u95f4\u7684\u901a\u8baf\uff0c\u5e76\u523a\u6fc0\u7ec6\u80de\u5411\u708e\u75c7\u3001\u611f\u67d3\u548c\u521b\u4f24\u7684\u90e8\u4f4d\u79fb\u52a8\u3002<\/p>\n<p>\u8fd9\u4e9b\u7ec6\u80de\u7684\u6c34\u5e73\u5347\u9ad8\u4f1a\u5206\u6ccc\u66f4\u591a\u7684\u7ec6\u80de\u56e0\u5b50\uff0c\u800c\u8fd9\u79cd\u201c\u7ec6\u80de\u56e0\u5b50\u98ce\u66b4\u201d\u4f1a\u62db\u52df\u66f4\u591a\u7684\u514d\u75ab\u7ec6\u80de\uff0c\u52a0\u901f\u4e00\u4e2a\u7ea7\u8054\u5faa\u73af\uff0c\u6700\u7ec8\u7834\u574f\u5bbf\u4e3b\u7684\u7ec4\u7ec7\u548c\u5668\u5b98\u3002<\/p>\n<p>\u8fd9\u53ef\u80fd\u5bfc\u81f4\u201c\u6e7f\u80ba\u201d\uff0c\u635f\u5bb3\u60a3\u8005\u7684\u80ba\u7ec4\u7ec7\uff0c\u5e76\u6700\u7ec8\u5bfc\u81f4\u6b7b\u4ea1\uff0c\u6b63\u5982\u4e00\u4e9b\u4f4f\u9662\u7684\u65b0\u51a0\u75c5\u6bd2\u60a3\u8005\u6240\u770b\u5230\u7684\u90a3\u6837\u3002<\/p>\n<p>IHL\u68c0\u6d4b\u7684\u6700\u9ad8\u6d53\u5ea6\u7684CBD\u548cHCQ\u572824\u5c0f\u65f6\u540e\u53ef\u4ee5\u5b8c\u5168\u6291\u5236\u7ec6\u83ccLPS\u5bf9PBMCs\u4ea7\u751f\u7684\u7ec6\u80de\u56e0\u5b50\u3002<\/p>\n<h2>\u521d\u6b65\u7ed3\u679c<\/h2>\n<p>Incannex\u9996\u5e2d\u79d1\u5b66\u5b98Mark Bleackley\u535a\u58eb\u8bf4\uff0c\u521d\u6b65\u5206\u6790\u7ed3\u679c\u5bf9\u8be5\u836f\u7269\u7684\u5f00\u53d1\u662f\u4e2a\u597d\u5146\u5934\u3002<\/p>\n<p>\u4ed6\u8bf4:\u201cCBD\u548cHCQ\u5f3a\u5927\u7684\u6297\u708e\u6d3b\u6027\u5bf9IHL-675A\u5728\u9884\u9632\u548c\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173ARDS\u65b9\u9762\u7684\u53d1\u5c55\u662f\u9f13\u821e\u4eba\u5fc3\u7684\u3002\u201d<\/p>\n<p>\u201c\u786e\u5b9aCBD\u548cHCQ\u7684\u6700\u4f73\u7ec4\u5408\u5c06\u6709\u52a9\u4e8eIHL-675A\u56fa\u5b9a\u5242\u91cf\u7ec4\u5408\u4ea7\u54c1\u7684\u8bbe\u8ba1\uff0c\u4f4e\u5242\u91cf\u836f\u7269\u53ef\u4ee5\u8fbe\u5230\u540c\u7b49\u529f\u6548\u6c34\u5e73\u201d\u3002<\/p>\n<p>\u8be5\u9879\u76ee\u7684\u4e0b\u4e00\u6b65\u5305\u62ec\u63a5\u53d7\u548c\u8bc4\u4f30\u4f53\u5916\u8054\u5408\u8bd5\u9a8c\uff0c\u7136\u540e\u8fdb\u884c\u7b2c2\u9636\u6bb5\u7684\u4f53\u5185\u7814\u7a76\uff0c\u4ee5\u8bc4\u4f30\u5728\u52a8\u7269\u73af\u5883\u4e0b\u7684\u6700\u4f73\u56fa\u5b9a\u5242\u91cf\u7ec4\u5408\u3002<\/p>\n<h2>SAARDS\u611f\u67d3<\/h2>\n<p>\u8113\u6bd2\u75c7\u53d1\u751f\u5728\u60a3\u8005\u7684\u514d\u75ab\u7cfb\u7edf\u5bf9\u611f\u67d3\u53cd\u5e94\u8fc7\u5ea6\uff0c\u4ea7\u751f\u8fc7\u91cf\u7684\u708e\u75c7\u7ec6\u80de\u56e0\u5b50\u6765\u5438\u5f15\u514d\u75ab\u7ec6\u80de\u3002<\/p>\n<p>\u5f53\u80ba\u88ab\u7ec6\u80de\u56e0\u5b50\u98ce\u66b4\u8fc7\u5ea6\u708e\u75c7\u53cd\u5e94\u7834\u574f\u65f6\uff0cSAARDS\u5c31\u4f1a\u53d1\u751f\u3002<\/p>\n<p>SAARDS\u7684\u7279\u70b9\u662f\u5e7f\u6cdb\u7684\u80ba\u90e8\u708e\u75c7(\u901a\u5e38\u88ab\u79f0\u4e3a\u201c\u6e7f\u80ba\u201d\u6216\u80ba\u708e)\u6291\u5236\u4e86\u60a3\u8005\u5145\u6c27\u8840\u6db2\u7684\u80fd\u529b\u3002<\/p>\n<p>\u5b83\u88ab\u8ba4\u4e3a\u662f\u5bfc\u81f4\u80ba\u90e8\u3001\u6ccc\u5c3f\u9053\u3001\u80c3\u90e8\u548c\u76ae\u80a4\u611f\u67d3\u4ee5\u53ca\u65b0\u51a0\u75c5\u6bd2\u611f\u67d3\u7684\u4e3b\u8981\u539f\u56e0\u3002<\/p>\n<p>\u51e0\u5341\u5e74\u6765\uff0cSAARDS\u7684\u6cbb\u7597\u4ec5\u9650\u4e8e\u4f7f\u7528\u6c27\u6c14\u547c\u5438\u673a\u6765\u6cbb\u7597\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u7684\u75c7\u72b6\uff0c\u800c\u4e0d\u662f\u611f\u67d3\u5f15\u8d77\u7684\u6f5c\u5728\u708e\u75c7\u201c\u53cd\u9988\u5faa\u73af\u201d\u3002<\/p>\n<p>\u76ee\u524d\u8fd8\u6ca1\u6709\u6ce8\u518c\u7684SAARDS\u836f\u7269\u6cbb\u7597\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e34\u5e8a\u671f\u5927\u9ebb\u7d20\u5f00\u53d1\u516c\u53f8Incannex Healthcare (ASX: IHL)\u5ba3\u5e03\uff0c\u5148\u5bfc\u836f\u7269IHL- 675a\u5728\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(SAARDS)\u65b9\u9762\u7684\u6297\u708e\u6d3b\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\uff0cSAARDS\u662f\u65b0\u51a0\u75c5\u6bd2\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002 \u5728\u4e00\u9879\u6d89\u53ca\u836f\u7269\u6210\u5206\u5927\u9ebb\u4e8c\u915a(CBD)\u548c\u7f9f\u6c2f\u55b9(HCQ)\u7684\u4f53\u5916\u5b9e\u9a8c\u4e2d\uff0cIncannex\u5df2\u7ecf\u786e\u5b9a\u4e86\u80fd\u591f\u5b8c\u5168\u6291\u5236\u4eba\u7c7b\u7ec6\u80de\u4e2d\u708e\u75c7\u751f\u7269\u6807\u5fd7\u7269\u2014\u2014\u7ec6\u80de\u56e0\u5b50\u7684\u6709\u6548\u6d53\u5ea6\u8303\u56f4\u3002 \u4ed6\u4eec\u76ee\u524d\u6b63\u5728\u7b49\u5f85\u4e24\u79cd\u836f\u7269\u8054\u5408\u4ea7\u54c1\u7684\u8bc4\u4f30\u7ed3\u679c\uff0c\u6839\u636e\u8be5\u7ed3\u679c\uff0c\u4e24\u79cd\u836f\u7269\u8054\u5408\u4f7f\u7528\u7684\u4f4e\u5242\u91cf\u7406\u8bba\u4e0a\u53ef\u4ee5\u8fbe\u5230\u76f8\u540c\u7684\u529f\u6548\u6c34\u5e73\uff0c\u6700\u5927\u9650\u5ea6\u5730\u51cf\u5c11\u4e0d\u826f\u53cd\u5e94\u7684\u53ef\u80fd\u6027\uff0c\u4ee5\u53ca\u5b9a\u4e49\u4e3aIHL-675A\u4ea7\u54c1\u7684\u63cf\u8ff0\u3002 \u6d4b\u5b9a\u65b9\u6cd5 \u8be5\u5b9e\u9a8c\u89c2\u5bdf\u4e86\u4ece\u4e09\u4e2a\u4e0d\u540c\u7684\u4f9b\u4f53\u4e2d\u5206\u79bb\u51fa\u7684\u4eba\u5916\u5468\u8840\u5355\u6838\u7ec6\u80de(PBMCs)\uff0c\u5e76\u5728\u7ec6\u83cc\u8102\u591a\u7cd6(LPS)\u8bf1\u5bfc\u708e\u75c7\u53cd\u5e94\u4e4b\u524d\u7528\u4e0d\u540c\u6d53\u5ea6\u7684CBD\u6216HCQ\u8fdb\u884c\u5904\u7406\u3002\u5b9e\u9a8c\u4e2d\u4e5f\u52a0\u5165\u4e86\u53ea\u6dfb\u52a0LPS\u7684\u672a\u5904\u7406\u5bf9\u7167\u7ec4\u3002 \u5728\u6bcf\u79cd\u7814\u7a76\u836f\u7269\u548cLPS\u5b58\u5728\u768424\u5c0f\u65f6\u6f5c\u4f0f\u671f\u540e\uff0c\u4f7f\u7528\u57fa\u4e8e\u53d1\u5149\u7684\u68c0\u6d4b\u65b9\u6cd5\u5bf9\u57f9\u517b\u57fa\u4e2d\u5173\u952e\u7684\u708e\u75c7\u7ec6\u80de\u56e0\u5b50\u6c34\u5e73\u8fdb\u884c\u5206\u6790\u3002 Incannex\u7814\u7a76\u53d1\u73b0\uff0cCBD\u548cHCQ\u5448\u201c\u7ebf\u6027\u6297\u708e\u5242\u91cf\u53cd\u5e94\u66f2\u7ebf\u201d\uff0c\u5373\u968f\u7740\u836f\u7269\u6d53\u5ea6\u7684\u589e\u52a0\uff0cPBMCs\u5728LPS\u523a\u6fc0\u4e0b\u4ea7\u751f\u7684\u7ec6\u80de\u56e0\u5b50\u51cf\u5c11\u3002 \u7ec6\u80de\u56e0\u5b50\u662f\u7ec6\u80de\u4fe1\u53f7\u5206\u5b50\uff0c\u5b83\u5728\u514d\u75ab\u53cd\u5e94\u4e2d\u5e2e\u52a9\u7ec6\u80de\u95f4\u7684\u901a\u8baf\uff0c\u5e76\u523a\u6fc0\u7ec6\u80de\u5411\u708e\u75c7\u3001\u611f\u67d3\u548c\u521b\u4f24\u7684\u90e8\u4f4d\u79fb\u52a8\u3002 \u8fd9\u4e9b\u7ec6\u80de\u7684\u6c34\u5e73\u5347\u9ad8\u4f1a\u5206\u6ccc\u66f4\u591a\u7684\u7ec6\u80de\u56e0\u5b50\uff0c\u800c\u8fd9\u79cd\u201c\u7ec6\u80de\u56e0\u5b50\u98ce\u66b4\u201d\u4f1a\u62db\u52df\u66f4\u591a\u7684\u514d\u75ab\u7ec6\u80de\uff0c\u52a0\u901f\u4e00\u4e2a\u7ea7\u8054\u5faa\u73af\uff0c\u6700\u7ec8\u7834\u574f\u5bbf\u4e3b\u7684\u7ec4\u7ec7\u548c\u5668\u5b98\u3002 \u8fd9\u53ef\u80fd\u5bfc\u81f4\u201c\u6e7f\u80ba\u201d\uff0c\u635f\u5bb3\u60a3\u8005\u7684\u80ba\u7ec4\u7ec7\uff0c\u5e76\u6700\u7ec8\u5bfc\u81f4\u6b7b\u4ea1\uff0c\u6b63\u5982\u4e00\u4e9b\u4f4f\u9662\u7684\u65b0\u51a0\u75c5\u6bd2\u60a3\u8005\u6240\u770b\u5230\u7684\u90a3\u6837\u3002 IHL\u68c0\u6d4b\u7684\u6700\u9ad8\u6d53\u5ea6\u7684CBD\u548cHCQ\u572824\u5c0f\u65f6\u540e\u53ef\u4ee5\u5b8c\u5168\u6291\u5236\u7ec6\u83ccLPS\u5bf9PBMCs\u4ea7\u751f\u7684\u7ec6\u80de\u56e0\u5b50\u3002 \u521d\u6b65\u7ed3\u679c Incannex\u9996\u5e2d\u79d1\u5b66\u5b98Mark Bleackley\u535a\u58eb\u8bf4\uff0c\u521d\u6b65\u5206\u6790\u7ed3\u679c\u5bf9\u8be5\u836f\u7269\u7684\u5f00\u53d1\u662f\u4e2a\u597d\u5146\u5934\u3002 \u4ed6\u8bf4:\u201cCBD\u548cHCQ\u5f3a\u5927\u7684\u6297\u708e\u6d3b\u6027\u5bf9IHL-675A\u5728\u9884\u9632\u548c\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173ARDS\u65b9\u9762\u7684\u53d1\u5c55\u662f\u9f13\u821e\u4eba\u5fc3\u7684\u3002\u201d \u201c\u786e\u5b9aCBD\u548cHCQ\u7684\u6700\u4f73\u7ec4\u5408\u5c06\u6709\u52a9\u4e8eIHL-675A\u56fa\u5b9a\u5242\u91cf\u7ec4\u5408\u4ea7\u54c1\u7684\u8bbe\u8ba1\uff0c\u4f4e\u5242\u91cf\u836f\u7269\u53ef\u4ee5\u8fbe\u5230\u540c\u7b49\u529f\u6548\u6c34\u5e73\u201d\u3002 \u8be5\u9879\u76ee\u7684\u4e0b\u4e00\u6b65\u5305\u62ec\u63a5\u53d7\u548c\u8bc4\u4f30\u4f53\u5916\u8054\u5408\u8bd5\u9a8c\uff0c\u7136\u540e\u8fdb\u884c\u7b2c2\u9636\u6bb5\u7684\u4f53\u5185\u7814\u7a76\uff0c\u4ee5\u8bc4\u4f30\u5728\u52a8\u7269\u73af\u5883\u4e0b\u7684\u6700\u4f73\u56fa\u5b9a\u5242\u91cf\u7ec4\u5408\u3002 SAARDS\u611f\u67d3 \u8113\u6bd2\u75c7\u53d1\u751f\u5728\u60a3\u8005\u7684\u514d\u75ab\u7cfb\u7edf\u5bf9\u611f\u67d3\u53cd\u5e94\u8fc7\u5ea6\uff0c\u4ea7\u751f\u8fc7\u91cf\u7684\u708e\u75c7\u7ec6\u80de\u56e0\u5b50\u6765\u5438\u5f15\u514d\u75ab\u7ec6\u80de\u3002 \u5f53\u80ba\u88ab\u7ec6\u80de\u56e0\u5b50\u98ce\u66b4\u8fc7\u5ea6\u708e\u75c7\u53cd\u5e94\u7834\u574f\u65f6\uff0cSAARDS\u5c31\u4f1a\u53d1\u751f\u3002 SAARDS\u7684\u7279\u70b9\u662f\u5e7f\u6cdb\u7684\u80ba\u90e8\u708e\u75c7(\u901a\u5e38\u88ab\u79f0\u4e3a\u201c\u6e7f\u80ba\u201d\u6216\u80ba\u708e)\u6291\u5236\u4e86\u60a3\u8005\u5145\u6c27\u8840\u6db2\u7684\u80fd\u529b\u3002 \u5b83\u88ab\u8ba4\u4e3a\u662f\u5bfc\u81f4\u80ba\u90e8\u3001\u6ccc\u5c3f\u9053\u3001\u80c3\u90e8\u548c\u76ae\u80a4\u611f\u67d3\u4ee5\u53ca\u65b0\u51a0\u75c5\u6bd2\u611f\u67d3\u7684\u4e3b\u8981\u539f\u56e0\u3002 \u51e0\u5341\u5e74\u6765\uff0cSAARDS\u7684\u6cbb\u7597\u4ec5\u9650\u4e8e\u4f7f\u7528\u6c27\u6c14\u547c\u5438\u673a\u6765\u6cbb\u7597\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u7684\u75c7\u72b6\uff0c\u800c\u4e0d\u662f\u611f\u67d3\u5f15\u8d77\u7684\u6f5c\u5728\u708e\u75c7\u201c\u53cd\u9988\u5faa\u73af\u201d\u3002 \u76ee\u524d\u8fd8\u6ca1\u6709\u6ce8\u518c\u7684SAARDS\u836f\u7269\u6cbb\u7597\u3002<\/p>\n","protected":false},"author":4,"featured_media":9136,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[33],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c<\/title>\n<meta name=\"description\" content=\"\u4e34\u5e8a\u671f\u5927\u9ebb\u7d20\u5f00\u53d1\u516c\u53f8Incannex Healthcare (ASX: IHL)\u5ba3\u5e03\uff0c\u5148\u5bfc\u836f\u7269IHL- 675a\u5728\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(SAARDS)\u65b9\u9762\u7684\u6297\u708e\u6d3b\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\uff0cSAARDS\u662f\u65b0\u51a0\u75c5\u6bd2\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c\" \/>\n<meta property=\"og:description\" content=\"\u4e34\u5e8a\u671f\u5927\u9ebb\u7d20\u5f00\u53d1\u516c\u53f8Incannex Healthcare (ASX: IHL)\u5ba3\u5e03\uff0c\u5148\u5bfc\u836f\u7269IHL- 675a\u5728\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(SAARDS)\u65b9\u9762\u7684\u6297\u708e\u6d3b\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\uff0cSAARDS\u662f\u65b0\u51a0\u75c5\u6bd2\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-08-25T23:44:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:46:42+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/Incannex-Healthcare-ASX-IHL-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies.jpg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c\" \/>\n<meta name=\"twitter:description\" content=\"\u4e34\u5e8a\u671f\u5927\u9ebb\u7d20\u5f00\u53d1\u516c\u53f8Incannex Healthcare (ASX: IHL)\u5ba3\u5e03\uff0c\u5148\u5bfc\u836f\u7269IHL- 675a\u5728\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(SAARDS)\u65b9\u9762\u7684\u6297\u708e\u6d3b\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\uff0cSAARDS\u662f\u65b0\u51a0\u75c5\u6bd2\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/Incannex-Healthcare-ASX-IHL-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/\",\"name\":\"Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-08-25T23:44:30+00:00\",\"dateModified\":\"2023-08-29T17:46:42+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u4e34\u5e8a\u671f\u5927\u9ebb\u7d20\u5f00\u53d1\u516c\u53f8Incannex Healthcare (ASX: IHL)\u5ba3\u5e03\uff0c\u5148\u5bfc\u836f\u7269IHL- 675a\u5728\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(SAARDS)\u65b9\u9762\u7684\u6297\u708e\u6d3b\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\uff0cSAARDS\u662f\u65b0\u51a0\u75c5\u6bd2\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c","description":"\u4e34\u5e8a\u671f\u5927\u9ebb\u7d20\u5f00\u53d1\u516c\u53f8Incannex Healthcare (ASX: IHL)\u5ba3\u5e03\uff0c\u5148\u5bfc\u836f\u7269IHL- 675a\u5728\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(SAARDS)\u65b9\u9762\u7684\u6297\u708e\u6d3b\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\uff0cSAARDS\u662f\u65b0\u51a0\u75c5\u6bd2\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c","og_description":"\u4e34\u5e8a\u671f\u5927\u9ebb\u7d20\u5f00\u53d1\u516c\u53f8Incannex Healthcare (ASX: IHL)\u5ba3\u5e03\uff0c\u5148\u5bfc\u836f\u7269IHL- 675a\u5728\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(SAARDS)\u65b9\u9762\u7684\u6297\u708e\u6d3b\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\uff0cSAARDS\u662f\u65b0\u51a0\u75c5\u6bd2\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/","og_site_name":"smallcapsCN","article_published_time":"2020-08-25T23:44:30+00:00","article_modified_time":"2023-08-29T17:46:42+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/Incannex-Healthcare-ASX-IHL-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies.jpg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_title":"Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c","twitter_description":"\u4e34\u5e8a\u671f\u5927\u9ebb\u7d20\u5f00\u53d1\u516c\u53f8Incannex Healthcare (ASX: IHL)\u5ba3\u5e03\uff0c\u5148\u5bfc\u836f\u7269IHL- 675a\u5728\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(SAARDS)\u65b9\u9762\u7684\u6297\u708e\u6d3b\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\uff0cSAARDS\u662f\u65b0\u51a0\u75c5\u6bd2\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/08\/Incannex-Healthcare-ASX-IHL-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies.jpg","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/","url":"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/","name":"Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-08-25T23:44:30+00:00","dateModified":"2023-08-29T17:46:42+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u4e34\u5e8a\u671f\u5927\u9ebb\u7d20\u5f00\u53d1\u516c\u53f8Incannex Healthcare (ASX: IHL)\u5ba3\u5e03\uff0c\u5148\u5bfc\u836f\u7269IHL- 675a\u5728\u6cbb\u7597\u8d25\u8840\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81(SAARDS)\u65b9\u9762\u7684\u6297\u708e\u6d3b\u6027\u65b9\u9762\u53d6\u5f97\u4e86\u79ef\u6781\u7684\u521d\u6b65\u7ed3\u679c\uff0cSAARDS\u662f\u65b0\u51a0\u75c5\u6bd2\u6b7b\u4ea1\u7684\u4e3b\u8981\u539f\u56e0\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/incannex-in-vitro-results-sepsis-associated-acute-respiratory-disease-drug-studies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Incannex\u516c\u5e03\u8113\u6bd2\u75c7\u76f8\u5173\u7684\u6025\u6027\u547c\u5438\u9053\u75be\u75c5\u836f\u7269\u7814\u7a76\u7684\u4f53\u5916\u7ed3\u679c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1819"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1819"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1819\/revisions"}],"predecessor-version":[{"id":9135,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1819\/revisions\/9135"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/9136"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1819"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1819"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1819"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}